Danelle Rolle-McFarland

As Clinical Research Scientist, Dr. Rolle-McFarland oversees OncoSynergy’s Chemistry, Manufacturing, and Control (CMC) Program, ensuring a cohesive collaboration among our CROs and expert CMC consultant. Prior to OncoSynergy, she completed a 1-year postdoc in Cancer Epidemiology at Moffitt Cancer Center, our Phase I clinical trial site, making her a natural fit to our team and mission. Furthermore, she translated the foundation of her postdoc work into developing and launching OncoSynergy’s tissue biomarker program, enabling collection of valuable data not usually captured in a Phase I trial. Dr. Rolle-McFarland received her BA in Chemistry from the College of Saint Benedict and a PhD and MPH from Purdue University, with a focus on Epidemiology and Public Health. She also authored several peer-reviewed publications, with her most recent contribution at OncoSynergy entitled “Endpoint in Ovarian Cancer Xenograph Model Predicted by Nighttime Motion Metrics,” which has been published in Nature Lab Animal.